12:00 AM
 | 
Jan 24, 2000
 |  BC Week In Review  |  Company News  |  Deals

BioSignal Inc., Hybrigenics SA deal

The companies will validate BioSignal’s Bioluminescence Resonance Energy Transfer (BRET) technology for confirming in mammalian cells protein-protein...

Read the full 65 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >